SCHEMBL26776349

SCHEMBL26776349

CC(C)(C)[Si](C)(C)Oc1c(Cl)cccc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
POLB P06746 1/20 0.46
APEX1 P27695 1/20 0.44
ALDH1A1 P00352 10/20 0.43
TDP1 Q9NUW8 4/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 2/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30286823 1.00 MAPT (0.46) MAPTPOLBAPEX1ALDH1A1TDP1
SCHEMBL5501219 0.84 TDP1 (0.42) MAPTPOLBALDH1A1TDP1KDM4E
SCHEMBL2880083 0.81 ALDH1A1 (0.40) MAPTPOLBALDH1A1TDP1KDM4E
SCHEMBL3242496 0.81 CYP1A2 (0.37) KDM4EKMT2ATSHRCYP1A2CYP3A4
SCHEMBL3721283 0.76 MAPT (0.57) MAPTPOLBAPEX1ALDH1A1TDP1
SCHEMBL26263547 0.75 ALDH1A1 (0.56) MAPTPOLBALDH1A1TDP1MEN1
SCHEMBL23589539 0.75 ALDH1A1 (0.44) MAPTALDH1A1TDP1KDM4EMEN1
SCHEMBL10026501 0.75 TDP1 (0.53) MAPTALDH1A1TDP1KDM4EKMT2A
SCHEMBL12378223 0.74 KDM4E (0.41) MAPTPOLBKDM4EGAACYP1A2
SCHEMBL8989557 0.74 HPGD (0.51) MAPTPOLBAPEX1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2024-08-27 US disclosed
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 US disclosed
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 US disclosed
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 US disclosed
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 US disclosed
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2022-05-31 US disclosed
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 MAPT 2850/4885POLB 4782/4885APEX1 4842/4885
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 MAPT 2850/4885POLB 4782/4885APEX1 4842/4885
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 MAPT 2850/4885POLB 4782/4885APEX1 4842/4885
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 MAPT 2850/4885POLB 4782/4885APEX1 4842/4885
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 MAPT 2850/4885POLB 4782/4885APEX1 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.